Blood flow stabilisation apparatus and method of application thereof

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to - physiotherapy. An apparatus comprises a power supply and a main component. The main component incorporates a body, a front cover, a back cover and a light source unit. And the light source unit accommodates at least one light-emitting diode. The front cover contains a polariser of polarisation efficiency more than 60 % for emission in a range 700 to 1000 nm. The light source unit is movable close and away from the front cover for power output adjustment of polarised emission directed on a patient's body. The method of application of the apparatus is characterised by the fact the human body area is exposed to polarised light generated by said apparatus. Exposure time is 10 to 15 minutes every day or every second day. 20 procedures are carried out.

EFFECT: apparatus and method allow varying circulating blood volume.

10 cl, 9 dwg

 

The present invention relates to a device for stabilizing blood flow and blood circulation by removing blood stasis caused by the substrate and impaired function of internal organs such as the brain and heart, to stimulate blood circulation and eliminate various metabolic disorders; a method of treatment using this device.

Qualitative and quantitative changes in the blood are very often the result of enzymatic reactions. For example, in 1964, when he supported theory of a cascade or waterfall for the first time it was recognized that blood coagulation is a process for the enzymatic reaction.

As the enzyme circulates in the form of inert enzyme predecessor, it behaves initially as the substrate, and then activated. The function of the enzyme is a biological process of activation, when a small amount of the enzyme activates a large number of substrate. At the same time, we can say that the function of enzymes is sonocatalytic process, when a small amount of enzyme produces a huge amount of the enzyme.

Different types of photoelectromagnetic therapy has long been used to enhance enzymatic reactions and body stimulation. In 1988 Between the national society of laser therapy classified laser therapy as high-intensity (HLLT) and low intensity (LLLT) laser therapy in accordance with the concepts of biological degradation and photobiological activation caused by laser beams. It is believed that cold laser therapy is a therapy, which uses biological activation of the laser and which is the use of synchronized and simple low-intensity laser therapy.

In the 1990s, as a result of the rapid development of scientific research to improve the effectiveness of treatment and to overcome the disadvantages of laser therapy instead of short-wavelength lasers were simultaneously apply lasers with different wavelengths, and were developed and used methods of intensive and moderate phototherapy.

In addition, in the spotlight polarization of visible light as the polarized light with different wavelength has the same or higher biological stimulation as cold laser therapy.

U.S. patents 5,073, 830 and 6,312,451 reveal that the use of polarized light initiates a harmonious building and rebuild poles ions on the surface polarization of lipids, thus, the potential difference is created between the lipid and protein, resulting activates cellular metabolism, due to the effect on the movement and activation of protein included in the roughened surface of the lipid, including combinations of protein in the cell membrane.

However, the drawback is preceded by the level of technology is that does not indicate what type of electromagnetic field and energy cause qualitative and quantitative changes in the blood, also was not disclosed offer for the induction of cell activation.

The present invention relates to a device for stabilizing blood flow and blood circulation by removing blood stasis caused by the substrate and impaired function of internal organs such as the brain and heart, to stimulate blood circulation and eliminate various metabolic disorders; a method of treatment using this device.

The proposed device consists of a power supply unit and the main body, comprising a housing, front cover, rear cover, the light source unit, the handle and cable. The light source unit has a set of LEDs emitting light of a near-infrared spectrum, the polarizer to polarize the light from the above-mentioned diode near-infrared spectrum and the radiative plate for heat dissipation from the LEDs. The power supply contains a step-down transformer that reduces AC 220 V to 3.5 V, analog-to-digital Converter, timer, lid switch, the light bulb and the output terminal for 3.5 Century.

In accordance with the invention, the selected range of wavelengths, is which protein to the cell membrane is restored to normal, thus, the enhanced activation due to correction of the molecular structure in the destruction of the phospholipids in the double lipid layer of some cell membranes. Further, in accordance with the invention is determined by the type and quantity of light energy which cause quantitative and qualitative changes in the blood by increasing the activation of the cells.

Declared stabilizing device has a coefficient of polarization of 60% or higher in the wavelength range of the near infrared spectrum.

Used the wavelength range from 700 nm to 1000 nm can cure and prevent disorders of the blood flow due to a qualitative change in blood or substrate, and functional disorders of the blood vessels. The energy density of polarized light in the region of the near infrared radiation is 10 mV/cm2if the average coefficient of polarization of light above 60%.

The heat source are LEDs; the prescribed temperature by contact with the body surface of the patient should not exceed 40°C.

The claimed invention discloses a method of treatment. The duration of therapeutic procedures is 10 or 15 minutes. The device can be applied to the forearm, you can sit or lie on the pillow, placing the device itself, and the time is controlled automatically.

The claimed device is creation can significantly increase blood volume and maintain the amount of calcium and magnesium at normal levels to prevent or eliminate the narrowing of the blood vessel.

The purpose of the claimed invention is to provide a device for managing qualitative and quantitative changes in the blood by physical methods, and the subsequent determination of the method of treatment. To resolve this problem by means of the present invention, on the basis of the biological status of the cell membrane, it is hypothesized that photoelectromagnetic field specific property corresponds to the molecular composition of the double lipid layer of the cell membrane or induces the rebuild process. In accordance with the invention, it is assumed that any change occurring in the cellular process or related to the cell membrane, called the aforementioned internal process. The cell membrane restricts the content of a cell within a certain volume and regulates the flow of ions and molecules inside and outside the cell.

Incoherent structure does not allow to distinguish substances from each other and to control the movement of individual molecules. Therefore, the cell membrane must be to some extent ordered.

This is possible if the molecules are free and can easily diffuse, and the cell membrane are mobile.

If we assume that the composition of the liquid crystal possesses these properties, and that the composition of cell membranes is similar to the composition of the liquid crystal, there who is very useful, that the above hypothesis can be implemented.

The main components of cell membranes is cholesterol and double layer of phospholipid molecules.

Protein is a long chain of amino acids, which are unevenly built into this double layer. This protein behaves as an enzyme and transports substances inside the cell and outside the cell. Phospholipids recognize loose hydrocarbon chain around the cell membrane and, as a result, initiate the reaction or interaction, necessary to ensure that cells have performed their respective functions.

The composition of phospholipids in the total mass suggests that the protein may be arranged in a special way.

Protein as the amino acid is the basic unit of the macromolecular liquid crystal of the new type.

The carboxyl group at one end of the amino acid reacts with the amino group at the other end and forms a chain of amino acids.

The result is a polypeptide macromolecule; mainly its structure is a long helical structure. This is the most solid macromolecule, and so when it is dissolved in water to high concentrations it has the form of a liquid crystal.

A complex of nucleic acid, for example DNA, composed of cellulose residues of phospholipids and have a pronounced form of a liquid crystal in which rastvorenii in protein liquid inside the cell.

Donorsponsored folded proteins - amino acids - perform various functions in a special way.

The interaction between proteins and phospholipids influences the formation of folds amino acids - proteins, which are very sensitive to activation and enzymatic reactions.

Therefore, maintaining the phospholipids of normal molecular order and the restoration of disturbed molecular patterns associated with qualitative and quantitative changes of circulating blood, which is vital to maintain normal physical health of the body.

The proposed device consists of a light source in the form of LEDs, power supply unit adjustment wavelength, timer and controller output.

Led is an element emitting light with a wavelength of from 700 nm to 1000 nm.

The power supply has an input voltage of 220 V (AC) and consists of a transformer regulated voltage with an output voltage of 3.5 V and schema conversion of alternating current into direct current.

The wavelength is adjusted by means of a parallel connection of LEDs with different wavelengths from 700 nm to 1000 nm.

Output power is adjustable by setting a certain distance between the led and the device field is Itachi light, integral with the shell.

With regard to the regulation of time, the duration of treatment procedure takes 10-15 minutes and is set each time depending on the condition of the body.

figure 1 - schematic representation of the stabilization device in accordance with the present invention;

figure 2 is a view in section of the device stabilization 1;

figure 3 is a view in section of the casing;

4 is a view in section of the polarizer;

5 is a view in section of the front cover;

6 is a view in section of the rear cover;

Fig.7 is a view in section of the handle;

Fig - view in terms of the emissivity of the wafer;

Fig.9 is a schematic diagram of a stabilization device in accordance with the present invention.

In Fig. 1 shows a schematic representation of the proposed stabilization device, which is generally designated position 10. The device 10 stabilization consists of the main part 20 and the power source 90.

In Fig. 2 shows a view in section of the device 10 stabilization. As shown in Fig. 2, the main part 20 includes a housing 30, the front cover 40, the rear cover 50, unit 60 of the light source, the handle 70 and the cable 80. The housing 30 is made in the form of a tube, inside of which is a thread 31 for screwing and unscrewing unit 60 of the light source so that the block 60 of the light source can move closer or Yes is the more from the front cover 40. The housing 30 is designed in such a way that it was occupied by the front cover 40 and the rear cover 50. The housing 30 is made from a material able to withstand external shocks, the penetration of contaminants and heat from the block 60 of the light source.

The front cover 40 serves as a stopper and includes a polarizer 41, which includes a polarizing film 42 and two protective plates 43; it corresponds exactly to the housing 30. Two protective plates 43 are respectively mounted on both surfaces of a polarizing film 42. The polarizer 41 polarizes light with a wavelength of from 700 nm to 1000 nm with a coefficient of polarization of 60%. The polarizer 41 is installed at a distance of 0.3~2.5 mm from the front cover 40, so that when used it was at a distance of 0.3~2.5 mm from the body surface.

The rear cover 50 serves as a stopper and has many holes 51 for heat dissipation from the housing 30.

The block 60 of the light source includes a radiation plate 61 in the form of a cylinder and a set of LEDs 62 bolted on its surface opposite to the polarizer 41, as shown in Fig. 2. The emissivity of the plate 61 has the same diameter as the inner diameter of the housing 30, and 63 is threaded on the perimeter, so that the block 60 of the light source can be moved closer and farther from the front cover 40 by means of screwing and unscrewing radiantly the plate 61. The emissivity of the plate 61 is made of aluminum with good heat conductivity in order to absorb heat from the LEDs 62 during use. The LEDs 62 are connected in parallel with each other and respectively emit light with different wavelengths from 700 nm to 1000 nm. The LEDs 62 are fixed on the emissivity of the plate 61 by nuts 64 and bolts 65. Because the block 60 of the light source can be moved back and forth, the energy density of the radiation is changed by changing a distance from the block 60 of the light source to the irradiated region.

The handle 70 is attached vertically to the housing 30 and serves to hold the device 10 stabilization in the desired position when in use and to protect the cable 80 that is placed inside it. The cable 80 is elastic and has a plug on one end 81 for connection with power 90 nutrition.

Block 90 supply contains a step-down transformer, step-down 220 VAC to 3.5 V, rectifier, the timer 96, the cover 91, the switch 92, the light bulb 93 and the output terminal 94 for 3.5 Century. On the cover 91, made of heat-resistant material, there are many holes on both sides, and the switch 92, the light bulb 93 and the output terminal 94 to 3.5 are in the front. The timer 96 allows you to set the optimal time during which the activation process in the cell membrane is regulated in accordance with technically and conditions for the block 60 of the light source, his energy density of radiation and radiation.

The device 10 stabilization has no restrictions regarding the form, and the block 60 of the light source can include one or more LEDs 62. Block 90 power can be calculated on a grid with 220 V or 110 V, can be operated by battery or rechargeable battery in the portable versions of the device 10 of the regulation.

In accordance with the technical specifications for the LEDs 62, emitting light with a wavelength of from 700 nm to 1000 nm, and the number of LEDs 62, the energy density of the radiation, the distance and time of radiation vary, and the irradiation region is from 8 to 20 cm2.

If the block 90 is connected to the 220 V through the plug 95, then lit light bulb 93 and the voltage of 220 VAC is reduced to 3.5 V, is converted to DC 3.5 using rectifier and transmitted to the output terminal 94. After the plug 81 of the housing 30 is inserted into the output terminal 94 3.5 In, turns on the switch 92 and the LEDs 62 are in working condition. The LEDs 62 with different wavelength emit light that passes through the polarizer 41 and is then converted into separate beams that are directed onto the surface of the body.

As for the method of treatment, place of treatment, procedure time and number of procedures are defined in C is depending on the condition of the patient. For example, if the patient has a disease associated with blood pressure, or respiratory failure, the device with polarized light superimposed on the area of Jen-Ying, i.e. horizontal intersection point Sterno sternocleidomastoid and toroidal cartilage, for 20 minutes daily and the required number of procedures is 20.

The evaluation is made by measuring the amount of cerebral blood flow by Doppler method and measurement of the content of magnesium and calcium in the blood.

Fifteen patients with impaired vertebral artery blood flow and other disturbances of cerebral blood flow have been tested on a number of cerebral blood flow and the content of magnesium and calcium in the blood.

The comparison group was not created. Instead, the results of measurements performed before and after treatment were compared with data for healthy people.

Table 1
The velocity of systolic blood flow and vascular resistance (X±SD)
ClassificationSystoleVascular resistance
Before the treatment71.0±8.6
After the treatment47.0±5.30.4±0.12

Table 2
The change in the calcium content compared before and after treatment
Before the treatmentAfter the treatment
11.37±2.4210.35±2.07

Table 3
Change the content of magnesium in comparison before and after treatment
Before the treatmentAfter the treatment
1.77±0.532.30±0.59

Table 4
The rate of change of calcium and magnesium compared before and after treatment
Before the treatmentAfter the treatment
5.52±1.121.86±0.74

As can be seen from the tables, the application stated ustroystvami.imeet narrowing of the blood vessel and greatly enhances the blood circulation.

1. Device for stabilizing blood flow containing the power supply and the main part, including housing, front cover, back cover and block the light source and the light source unit includes at least one led emitting in the range from 700 to 1000 nm, and the front cover contains a polarizer with a polarization ratio of over 60% for radiation in the range from 700 to 1000 nm, with the light source unit is arranged to move closer and farther from the front cover to regulate the output power of polarized radiation directed on the body.

2. The device according to claim 1, in which the body further comprises a handle.

3. The device according to claim 1, wherein said at least one led attached to the radiation plate in the light source unit.

4. Device according to any one of claims 1 to 3, wherein the light source contains a set of LEDs, each of which emits light with different wavelengths in the range from 700 to 1000 nm.

5. The device according to claim 4, in which the LEDs are connected in parallel.

6. The device according to claim 1, in which the polarizer attached to the front cover so that it is removed from the surface of the body of 0.3-2.5 mm when using the device.

7. The device according to claim 1, wherein the polarizer has a size of 8-20 cm2.

8. Device is according to claim 1, in which the polarizer includes a polarizing film and two protective plates that are bonded to both surfaces of the polarizing film, respectively.

9. The application of the device to stabilize blood flow according to any one of claims 1 to 8, characterized in that the polarized light from the specified device is irradiated area of the body, while the exposure time is about 10 to 15 minutes every day or every other day, and the number of procedures is 20.

10. The method according to claim 9, in which said device is placed on the skin of a person or attach the device to a stationary items, such as chair, sofa, pillow, bed.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention refers to medicine, oncology, and concerns combination treatment of stage IIIA-IIIB locally advanced non-small-cell lung cancer (LA NSCLC). A method involves preoperative chemotherapy according to the schedule paclitaxel 175 mg/m2 intravenously drop-by-drop on the 1st day and carboplatin AUC 6 intravenously drop-by-drop on the 1st day, 2 courses every 3 weeks, then a radical surgery combined with intraoperative radiation therapy on regional lymphatic cancer spreads in a single dose 15 Gy with underlying cisplatin radiosensitisation. The surgery involves combined operations with resection of a chest wall, and/or a diaphragm, and/or an oesophagus, and/or great vessels, and/or a pericardium, and/or auricles with the resected regions to be covered by the intraoperative radiation.

EFFECT: method provides improved survival rate in the patients suffering stage IIIA-IIIB LA NSCLC ensured by higher respectability of a tumour process, reduced rate of local recurrences and remote metastases.

2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to pulmonology, and can be used in treating recurrent, chronic obstructive and nonobstructive bronchitis, acute complicated (severe) pneumonia, multiple bronchiectasis. A nasal and pharyngeal mucosa and a paravertebral reflexogenic zone at C3 - C4 and Th2 - Th5 levels are exposed to helium-neon laser emission (HNLE) of wave length 0.63 mcm in a constant mode, while projections of affected lung and bronchi zones and a pulmonary artery are exposed to infrared laser radiation (IRLR) of wave length 0.78-1.30 mcm in a pulse mode. It is preceded by determining a degree of inflammation activity (DIA) derived from a value of an integrative inflammation activity index (IAI). The IAI is calculated by formula: IAI = (IAIclin+IAIhem+IAIcytol):3, where IAIclin is a clinical IAI equal to X points of clinical inflammation activity markers of (CIM), n=8; IAIhem is a hematological IAI equal to Σ points of hematological CIMs, n=9; IAIcytol, is a cytological IAI equal to £ points of cytological CIMs, n=7. The absence of inflammation is diagnosed by the integrative IAI up to 0.1 points, the Ist DIA - by the IAI ranging within 0.1-1.1 point, the IInd DIA - by the IAI within 1.2-2.1 points, the IIIth DIA - by the IAI within 2.2 - 3.0. The the Ist DIA requires the HNLE exposure of the nasal, pharyngeal mucosa and the paravertebral reflexogenic zone at C3 - C4 and Th2 - Th5 level. Total power flow density (PFD) is 2.94-6.05 J/cm2 for 4 min 55 sec - 9 min 05 sec in the course of 5-6 daily procedures. The IInd DIA requires the HNLE exposure of the nasal, pharyngeal mucosa and the paravertebral reflexogenic zone at C3 - C4 and Th2 - Th5 level and the IRLR exposure of a projection· of the affected lung and bronchi zones and the pulmonary artery with total PFD 3.04-6.46 J/cm2 for 7 min 55 sec - 14 min 05 sec in the course of 7-8 daily procedures. The IIIrd DIA requires the IRLR exposure of the projections of the affected lung and bronchi zones and the pulmonary artery at total PFD 0.51-1.82 J/cm2 for 16 min 00 sec - 22 min 30 sec in the course of 9-10 daily procedures.

EFFECT: method enables more effective correction of inflammation activity in bronchopulmonary diseases in children and adolescents with no cases of complications and side effects that indicates its safety, reduced length of inpatient treatment, prolonged remission, to decreased drug load.

7 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to - physiotherapy. A method involves simultaneous processing of an area containing microorganisms by a photosensitiser and photocatalyst composition. Thereafter they are kept for a period of time required for effective binding of the composition and microorganism cells. Then this area is exposed to optical radiation at wave length related to a maximal photosensitiser and photocatalyst absorption and power density required for composition activation. The photosensitiser is indocyanine green. The photocatalyst is titanium dioxide nanoparticles.

EFFECT: method provides more effective inactivation of pathogenic and opportunistic microorganisms ensured by higher microorganism radiosensitivity.

8 cl, 5 dwg

FIELD: medicine.

SUBSTANCE: invention is referred to medicine, physiotherapy. A method involves simultaneous processing of an area containing microorganisms by a photosensitiser and photocatalyst composition. They are kept for a period of time required for binding of the composition and microorganism cells. Then this area is exposed to optical radiation. An emission wavelength relates to a maximal photosensitiser and photocatalyst absorption and power density required for composition activation. The photosensitiser is methylene blue or/and brilliant green, and the photocatalyst is titanium dioxide nanoparticles.

EFFECT: method provides an effective microorganism inactivation with using the lower concentration of the photosensitiser ensured by simultaneous use of the photocatalyst and the photosensitiser.

9 cl, 3 tbl, 3 dwg

FIELD: medicine.

SUBSTANCE: procedures are enables by using gas-flow laser emission and spaying in a mixing chamber a liquid of a boiling point exceeding body temperature. Liquid temperature is specified as TL≤Tsur[1+λe/(αδe)]-[λe/(αδe)]T0, where λe, δe are a heat conduction coefficient and a skin surface thickness respectively, α is a skin surface thermal conductivity coefficient, T0 is initial skin surface temperature, Tsur is required skin surface temperature. Gas temperature is specified 5-20°C higher than liquid temperature. Then, a working chamber containing a radiolucent optical window is used to supply a gas-drop mixture flow parallel to the skin surface and sucked on an outlet of the working chamber. A laser emission cycle is preceded by completion of supplying the liquid in the mixing chamber, while been accompanied by supplying the gas flow.

EFFECT: method enables uniform temperature control of the skin surface and subcutis without mechanical skin pressure due to crosswise exposure to the pure gas flow combined with laser emission.

2 dwg

FIELD: medicine.

SUBSTANCE: method involves exposure of a object of therapy to low-intensity modulated visible or infrared electromagnetic radiation. The exposure is enabled by radiation pulse of duration 2 to 4 ms. Pulse interval duration is 9 to 12 ms.

EFFECT: method provides more efficient exposure ensured by increased permeability of cell membranes.

FIELD: medicine.

SUBSTANCE: method involves exposure of a object of therapy to low-intensity modulated visible or infrared electromagnetic radiation. The exposure is enabled by radiation pulse of duration 2 to 4 ms. Pulse interval duration is 9 to 12 ms.

EFFECT: method provides more efficient exposure ensured by increased permeability of cell membranes.

FIELD: medicine.

SUBSTANCE: it involves fractal analysis of the parameters of a derived path projection of a body centre of gravity on a horizontal plane and the parameters of cardiac rhytmogram by means of a radar sensor. The human body condition is estimated on a phase plane by the fractal parameter values of the path projection of the body centre of gravity on the horizontal plane and the fractal parameter of cardiac rhytmogram.

EFFECT: method extends the range of products for making an integral estimation of the body condition.

3 dwg

FIELD: medicine.

SUBSTANCE: photodynamic therapy of skin, mucosa and nails is enables by coating the injured areas with a photosensitiser for outward application 0.2-0.4 g per 1 cm2 of exposition 0.5-3 h and covering with a lightproof bandage. It is followed with laser exposure at wave length related to maximum absorption of the used photosensitser, at light energy dose 200 to 400 J/cm2.

EFFECT: method allows avoiding the recurrent disease ensured by exposure on underlying skin tissues, mucous membranes and in depth of a nail plate.

4 cl, 4 ex

FIELD: medicine.

SUBSTANCE: treatment of oropharyngeal squamous cell carcinoma is ensured by drop-by-drop introduction of cetuximab 400 mg/m2 for the first day of the first week. Then from the first day of the second week, radiation therapy of large fractions 4 Gy is combined with introduction of cisplatin 30 mg for 3 days running. On the first day of the second to the fifth week, cetuximab 250 mg/m2 is introduced drop-by-drop. Further, a dose of radiation therapy is 2 Gy once a day, 5 times a week to total basic dose 30-40 Gy. In 2 weeks, the course is performed again to total basic dose 70 Gy according to the same scheme.

EFFECT: method allows increasing rate and degree of primary tumour regress, suppressing sub-clinical disseminated metastases, ensuring maximum anticancer effect without injuring normal tissue cells, enables preserving organ functions, increasing a number of organ-saving surgeries, improving quality of life of the patients, reducing invalidisation.

2 ex

FIELD: medicine.

SUBSTANCE: invention refers to psychophysiology. The acupuncture points 26XIII zhen-chzhun, VM3 in-tan are localised and marked by a colour. A full-face photography 10×15 cm is taken to draw a vertical straight line through two marked points. The pupil centres are marked to draw therethrough vertical and horizontal lines respectively parallel and perpendicular to a sagittal face midline line of the person and within the accuracy of 0.1 mm. A hemispheric asymmetry coefficient is calculated: Kas=0.1×A/(C-D)±B, where A is a horizontal distance of the pupil centres; B is a vertical distance of the pupil centres - with a "+" sign, if a right eye is higher than a left one; with a "-" sign, if a left eye is higher than a right one; O is a distance of the right pupil centre and the face midline; D is a distance of the left pupil centre and the face midline. At the coefficient Kas values are within 0 to 5.0, a right-hemispheric asymmetry is stated, while the Kas values -5.0 to 0 show a left-hemispheric asymmetry. A degree of asymmetry increases with the Kas value approaching to zero, and the Kas value equal to zero testifies to the presence of the complete hemispheric symmetry.

EFFECT: method extends the range of products for evaluating the hemispheric asymmetry.

5 dwg, 2 tbl, 6 ex

FIELD: medicine.

SUBSTANCE: scapulohumeral periarthrosis is treated by nonsteroid anti-inflammatory drugs, anaesthetics and vitamins, by local cryotherapy with using Kryotur 600 apparatus immediately followed by neuropulse cuppent therapy. An acute period of the disease requires cryotherapy at temperature (-6) - (-12)°C for 8-10 minutes. In a subacute period not accompanied by secondary synovitis phenomena, cryotherapy is carried out at (0) - (-6)°C for 5-10 minutes. 4 procedure fields are exposed to neuropulse current. The IV channel electrodes are crosswise fixed within a shoulder joint; the I channel electrodes are arranged longitudinally in a paravertebral area on an affected side at a level of the I-III thoracic vertebras; the II channel electrodes are found paravertebrally on an opposite side; the III channel electrodes are fixed within a deltoid muscle. The operating mode of all the channels is group-mixed with pulse current frequency of the IV channel is fixed and equal to 100 Hz, the channel current migration period is 8 seconds. The neuropulse current exposure time is 10-15 minutes. The therapeutic course is 8-10 daily procedures.

EFFECT: higher clinical effectiveness ensured by pain syndrome relief, increased range of shoulder joint movement and lower number of carried out physiotherapeutic procedures.

4 ex

FIELD: medicine.

SUBSTANCE: method involves exposure on acupuncture points. For this purpose, from the 5th-7th menstrual day the acupuncture points E 36 (2), GI 4 (2), Rp 6 (2), E 28 (2), I 4 (1) are exposed. The exposure is performed by means of needles for 10-20 minutes. After the needles are removed, an underbelly is exposed to a variable electrostatic field. The exposure is enabled by Chivamat 200 apparatus. A labile procedure is used. For this purpose, the 5-minute exposure of frequency 190 Hz, intensity 80 %, pulse/pause length - 2/1. For the following 5 minutes, the exposure characteristics are as follows: frequency 50 Hz, intensity 80 %, pulse/pause length - 2/1. The therapeutic course is 7-10 procedures.

EFFECT: method reduces time of treatment, is easy-to-implement.

2 cl, 2 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely - to dentistry and physiotherapy. The method involves acupuncture of auricular points (AP). Every second day, the AP 4 are exposed to a portable electrode of DiaDENS apparatus and a red-light semiconductor laser of Svetozar apparatus. The exposure to DiaDENS apparatus is performed in a "Therapy" mode at frequency 77 Hz for 2 minutes. The exposure to Svetozar apparatus is characterised by wave length 665 nm for 1 minute. The therapeutic course is 7-8 sessions.

EFFECT: method reduces length of procedure and treatment, prolongs remission, improves patient's quality of life due to dysarthria elimination, considerable xerostomia reduction, neurologic semiology relief.

2 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to psychiatry. Method includes determination of form of tobacco addiction and further impact taking into account its form. In case of dissociated form of tobacco addiction impact is performed on adrenergic, dopaminergic and glucocorticoid biologically active systems homolaterally from the left side, and on estrogenic, histaminergic and alimentary systems - bilaterally from both sides. In case of psychosomatic form of tobacco addiction impact is performed on androgenic, adrenergic and dopaminergic biologically active systems homolaterally from the left side, and on histaminergic and alimentary systems - bilaterally from both sides. Impact is performed by method of bioresonance therapy with application of corresponding for each system homeopathic preparation: estradiol-composite, androstendiol-composite, adrenalin-composite, dopamine-composite, glucocorticoid-composite, histamine-composite in hundredth homeopathic potencies and nicotine-composite in two hundredth homeopathic potencies. Impact is performed on all or separate arm or leg meridians of male patient. Impact duration on each biologically active system constitutes 3 minutes. Course of treatment includes 6-15 sessions.

EFFECT: method increases remission duration.

4 cl, 2 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to psychiatry. Method includes determination of form of tobacco addiction and further impact on organism systems taking into account its form. In case of dissociated form of tobacco addiction impact is performed on androgenic, adrenergic and dopaminergic biologically active systems homolaterally from the right side, and on histaminergic and alimentary - bilaterally from both sides. In case of psychosomatic form of tobacco addiction impact is performed on androgenic, adrenergic and dopaminergic biologically active systems homolaterally from the left side, and on glucocorticoid and alimentary systems - bilaterally from both sides. Impact is performed by bioresonance therapy with application of corresponding for each system homeopathic preparation: androstenediol-composite, adrenalin-composite, dopamine-composite, glucocorticoid-composite, histamine-composite in hundredth homeopathic potencies and nicotine-composite in two hundredth homeopathic potencies. Impact is performed on all or separate arm or leg meridians of female patient. Impact duration on each biologically active system constitutes 3 minutes. Course of treatment includes 6-15 sessions.

EFFECT: method increases remission duration.

4 cl, 2 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to cardiosurgery and can be used in treatment of patients after cardiosurgical interventions and receiving mechanical ventilation (ALV). Starting with the first post-operation day at the background of intensive therapy in lying position of patient visceral manual therapy on organs of abdominal cavity is carried out. After that impact is performed on biologically active points which are selected taking into account prevailing organ failure. Depending on state of patient's conscience either passive or active movements in joints of lower extremities are performed. In case of active movements doctor exercises dosed resistance to working extremity. Before beginning and in pauses between exercises rotation in hip joint is performed. After that, ventilation in prone-position is carried out. Slow transfer of patient into sitting position is carried out. In this position impact is performed on patient's back by means of manual therapy techniques. After that patient is placed into orthopedic arm-chair in "vertical sitting" position with gradual increase of exposure time.

EFFECT: method makes it possible to restore and support adequate function of gastrointestinal tract, facilitate early independent beginning of enteral feeding, improve ventilation function of lungs and gas-transport function of blood.

3 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to dentistry. Method includes impact by remote electrode of apparatus "DiaDENS". Impact is performed with frequency 77 Hz for 2 minutes. Impact is performed on auricular points of acupuncture, which correspond to teeth of upper AT5, or lower AT6 jaws. When impact on auricular points is over, impact on pain zone in area of apex of cured tooth is performed. Impact is realised by point electrode of "DiaDens" apparatus with frequency 200 Hz, for 5 minutes.

EFFECT: method ensures obtaining high therapeutic result due to complex successive impact: reduces treatment terms, contributes to elimination of accompanying neurologic symptoms: sleep disorders, irritability, anxiety.

2 ex, 3 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to psychiatry, psychotherapy. At the beginning of session psychotherapeutic influence is performed. After that, corporal biologically active points (BAP) are subjected to impact of extremely high-frequency radiation with low-frequency modulation (EHF-LF). Then, phonoresonans therapy is carried out. Impact of EHF-LF radiation is performed on the following corporal BAP: Hae-Gu (Gi-4), Qu Chi (Gi-11), Zhong-fu (P-1), bai-hui (T-20). In case of depressed states impact is performed on Chung-Fu (P-1), fen-fu (T-16), bai-hui (T-20), Hsin-hui (T-22). In case of phobic states impact is performed on Feng-fu (T-16), bai-hui (T-20), da-lin (MS-7), Jung-Fu (P-1). In case of post-trauma stress disturbance impact is performed on Chung-Fu (P-1), Hae-Gu (Gi-4), shen-men (C-7), Feng-chi (VB-20). In case of sleep disorders impact is performed on Chung-Fu (P-1), Hae-Gu (Gi-4), Lin Tao (C-4), shen-men (C-7). For impact with EHF radiation not less than two corporal BAP are used.

EFFECT: method reduces terms of relief of pathologic psychic states reduction and increases remission duration.

4 cl, 7 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely - to reflexotherapy, psychiatry, addictology. At the withdrawal syndome peak, a complex treatment involves millimeter wave therapy (MWT) of biologically active points (BAP) and nutrition. The MWT exposure is conducted in a pseudonoise radiation mode, frequency range 54 - 70 GHz, output power up to 0.3 mWt, procedure duration 30 minutes. The main MWT procedures are performed on 1st-5th and 8th-9th therapeutic days. In 1 and 6 months, supportive therapeutic courses including 1-3 MWT sessions are carried out. In the patients with a body weight index (BWI) not exceeding 25 units, nutrition does not require caloric value limitation. In the patients with the BWI exceeding 25 units, nutrition requires caloric value limitation. That is ensured by limited consumption of simple carbohydrates and animal fats up to 10 % each from the caloric value, and by enrichment with protein up to 25 % from the caloric value, with vegetable fats - up to 20 % from the caloric value, with cellulose - up to 30 g.

EFFECT: method provides the prevention of body weight gain and other withdrawal syndrome manifestations during smoking cessation without additional use of a drug-induced therapy.

2 ex

FIELD: medicine.

SUBSTANCE: method involves administering diet with high content of nutrient fibers and restricted amount of ordinary hydrocarbons, animal fats and meat broth. Massage is done with manual massage machine Acupress being four-roller bronze or ebonite massage instrument operating along small intestine during 5-6min and then with movements across the abdomen from left to right during 3-4 min. The like movements are done with two-roller bronze or ebonite massage instrument operating along large intestine meridian symmetrically relative to the right and left arm during 4-5 min. All massage movements are done slowly. Procedures are given daily in the morning on empty stomach, before dinner and before going to bed.

EFFECT: enhanced effectiveness in treating chronic constipation cases.

4 dwg

Up!